These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12099725)

  • 1. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy.
    James J; Zhang Y; Wright K; Witt S; Glascock E; Osinska H; Klevitsky R; Martin L; Yager K; Sanbe A; Robbins J
    J Mol Cell Cardiol; 2002 Jul; 34(7):873-82. PubMed ID: 12099725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy.
    Sanbe A; Nelson D; Gulick J; Setser E; Osinska H; Wang X; Hewett TE; Klevitsky R; Hayes E; Warshaw DM; Robbins J
    Circ Res; 2000 Aug; 87(4):296-302. PubMed ID: 10948063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy.
    Lee W; Hwang TH; Kimura A; Park SW; Satoh M; Nishi H; Harada H; Toyama J; Park JE
    Am Heart J; 2001 Feb; 141(2):184-9. PubMed ID: 11174330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of ventricular essential myosin light chain disturb myosin binding and sarcomeric sorting.
    Lossie J; Ushakov DS; Ferenczi MA; Werner S; Keller S; Haase H; Morano I
    Cardiovasc Res; 2012 Mar; 93(3):390-6. PubMed ID: 22131351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
    Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice.
    Kazmierczak K; Muthu P; Huang W; Jones M; Wang Y; Szczesna-Cordary D
    Biochem J; 2012 Feb; 442(1):95-103. PubMed ID: 22091967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.
    Huang W; Kazmierczak K; Zhou Z; Aguiar-Pulido V; Narasimhan G; Szczesna-Cordary D
    Arch Biochem Biophys; 2016 Jul; 601():121-32. PubMed ID: 26906074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
    Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
    Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gradient of myosin regulatory light-chain phosphorylation across the ventricular wall supports cardiac torsion.
    Davis JS; Hassanzadeh S; Winitsky S; Wen H; Aletras A; Epstein ND
    Cold Spring Harb Symp Quant Biol; 2002; 67():345-52. PubMed ID: 12858559
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular biology and pathophysiology of hypertrophic cardiomyopathy due to mutations in the beta myosin heavy chains and the essential and regulatory light chains.
    Epstein ND
    Adv Exp Med Biol; 1998; 453():105-14; discussion 114-5. PubMed ID: 9889820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin.
    Mettikolla P; Calander N; Luchowski R; Gryczynski I; Gryczynski Z; Zhao J; Szczesna-Cordary D; Borejdo J
    J Theor Biol; 2011 Sep; 284(1):71-81. PubMed ID: 21723297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
    Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
    J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction.
    Muthu P; Wang L; Yuan CC; Kazmierczak K; Huang W; Hernandez OM; Kawai M; Irving TC; Szczesna-Cordary D
    FASEB J; 2011 Dec; 25(12):4394-405. PubMed ID: 21885653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.